Purpose. Surgical management of autosomal dominant polycystic kidney disease (ADPKD) in patients awaiting renal transplantation is a challenging task. Results. Overall patient and graft survival were 97 and 96% at 1 year and 93 and 80% at 5 years, respectively. Serum creatinine at current follow-up was 1.49 (0.8-2.8) mg/dL. Surgical complications, which might be associated with simultaneous nephrectomy requiring re-operation, occurred in 12% (lymphocele 4%, hernia 4%, post-operative haematoma or bleeding 4%). None of the patients died peri-operatively. Conclusion. Renal transplantation with simultaneous unilateral nephrectomy in ADPKD is a reasonable procedure for patients suffering from massively enlarged native kidneys.
Introduction
Autosomal dominant polycystic kidney disease (ADPKD) is the underlying disease in 5-10% of patients on renal replacement therapy [1] [2] [3] . In ADPKD, progressive expansion of multiple bilateral renal cysts leads to massive kidney enlargement with simultaneous shrinkage of normal renal parenchyma and subsequent renal failure. In addition, patients with ADPKD often develop recurrent urinary tract infections, nephrolithiasis, back or abdominal pain as well as abdominal discomfort causing early satiety [4] [5] [6] .
Due to improvements in conservative therapy, the nephrectomy rate in patients with ADPKD has steadily declined over the past decades [7] . Today, there is a general consensus that pre-transplant native nephrectomy, especially bilateral nephrectomy, should be avoided [8, 9] . However, the optimal management of patients with ADPKD awaiting renal transplantation in terms of pre-, simultaneous or post-transplant nephrectomy is unclear. Most centres do not recommend nephrectomy unless serious complications like infection or bleeding arise. Others suggest a 'sandwich' technique with single-sided nephrectomy before and removal of the remaining polycystic kidney after transplantation [10, 11] . However, this concept implies a total of three operative procedures.
Simultaneous nephrectomy together with renal transplantation has gained high patient acceptance by reducing the total number of operative procedures. Two different concepts have been reported: an extraperitoneal staged procedure with ipsilateral simultaneous native nephrectomy and contralateral nephrectomy before or after renal transplantation [12, 13] or the simultaneous bilateral approach via an intra-peritoneal access [14] [15] [16] . Unfortunately, most series are rather small [8, [13] [14] [15] [16] [17] [18] .
At the University of Freiburg, kidney transplantation with concomitant native nephrectomy was first introduced in 1987 and became standard at our institution as of April 1998. Consequently, simultaneous nephrectomy was performed in every patient with ADPKD at the time of transplantation irrespective of present symptoms.
Goal of the study
Concern has been raised as to whether patients undergoing a simultaneous approach are at an increased risk for post-operative complications, which might deteriorate patient and graft survival after renal transplantation. We report our experience with 100 consecutive adult kidney transplantations with simultaneous nephrectomy.
Materials and methods

Patients
A total of 3156 renal transplantations were performed from 1968 until January 2011. Of these, 1136 were transplanted between April 1998 and January 2009 including 100 patients with ADPKD. Patients were routinely offered a simultaneous unilateral operative procedure and informed consent was obtained at the time of listing and was repeated at the day of transplantation. Patients eligible for this approach fulfilled all acceptance criteria for the waiting list without additional requirements. This series includes the follow-up of 32 patients from a previous publication [12] .
Surgical technique
Nephrectomy was indicated on the right side irrespective of size in all patients including asymptomatic patients. Only in symptomatic patients with evidence of chief complaints caused by the left native kidney, did we adopt the procedure to the left side including the engraftment of the kidney transplant. The diagnosis of ADPKD was based on medical history, physical examination, ultrasound and/or computerized tomography and was confirmed by post-operative histological evaluation. The surgical technique involved ipsilateral nephrectomy via an extraperitoneal curvilinear incision in the lower abdominal quadrant (Gibson incision), which is also used for renal transplantation alone at our institution. In massively enlarged native kidneys, the incision was extended ∼5-8 cm cranially. The renal artery and renal vein were clamped and ligated separately with #0 braided polyglactin and oversewn with 3-0 monofilament polypropylene suture (see Figure 1 ). Before kidney engrafting, the operation site was then rinsed with anti-septic solution [Ringer's solution with polyethylene glycol, polyhexanide 0.04% (LAVANID ® 2); Serag-Wiessner KG, Naila, Germany]. Pre-operative intravenous single-shot antibiotic prophylaxis was administered.
Immunosuppression
Maintenance immunosuppressive therapy was based on cyclosporine A (CSA) (n = 55) or tacrolimus (TAC) (n = 45) together with mycophenolate mofetil (MMF) and prednisone (PRED). Induction therapy with anti-thymocyte globulin or anti-interleukin-2 receptor antibodies (Basiliximab; Novartis Pharma, Switzerland) was used in patients with panelreactive antibodies above 30%, non-related living donor kidney transplants and in all ABO blood group-incompatible transplantations. ABOi (ABO blood group-incompatible) transplantations were treated as follows. Patients received 375 mg/m 2 rituximab intravenous 3-4 weeks before transplantation. Immunosuppressive therapy consisted of TAC, mycophenolate mofetil and PRED and was started at least 7 days before transplantation. Intravenous immunoglobulins (0.5 g/kg) were administered the day before transplantation. Immunoglobulin G (IgG)-anti-A or -B Ab titres before starting immunoadsorption treatment ranged between 1:4 and 1:1024. Immunoadsorption treatment was started in parallel with immunosuppressive medication and was continued until the anti-A or anti-B Ab titres (IgG and IgM) were lowered to the aimed pre-transplant threshold of <1:8. During the early post-operative period, additional immunoadsorption treatments were performed, if the titres increased again above 1:8 (Days 0-7) or 1:16 (Days 8-14), respectively [19] .
Acute rejections were treated with 500 mg PRED for 3 days, steroidresistant rejection episodes with anti-thymocyte globulin. Deceaseddonor kidney grafts were preserved in University of Wisconsin solution (ViaSpan™, DuPont Pharmaceuticals, Bad Homburg, Germany) until 2004 and in Histidine-Tryptophan-Ketoglutarate (HTK) solution (Custodiol HTK™; Dr Franz Köhler Chemie GmbH, Alsbach-Hähnlein, Germany) thereafter. Grafts from living donation were exclusively preserved in HTK solution. Organ allocation was based on presence of a negative cross match, waiting time and human leukocyte antigen match according to the Eurotransplant criteria. Living-donor kidney transplantation was performed in accordance with ABO blood group compatibility in all but 11 patients. Data on each individual were obtained from a retrospective chart review and from a prospective post-transplant database.
Follow-up
The corresponding registration office in Germany provided follow-up data including survival. Patient characteristics are shown in Table 1 .
Statistical analysis
Values are expressed as means ± SEM unless otherwise stated. Patient and graft survival were calculated according to the Kaplan-Meier method (SPSS for Windows 15.0, SPSS Inc., Chicago, IL). Graft failure was defined either as return to maintenance dialysis including removal of the graft for any reason or graft loss due to patient death with functioning graft. There were no exclusions. Peri-operative complications and patient death were defined as events occurring within 90 days after transplantation.
Results
The proportion of patients with ADPKD undergoing renal transplantation was 9%. Mean follow-up was 3.0 years (range 0.8-10.0 years). Patients underwent unilateral nephrectomy before renal transplantation on the right side in all but 15 cases (left side). Overall patient survival at 1 and 5 years was 97 and 95%, respectively. The corresponding graft survival at 1 and 5 years was 96 and 80%, respectively (see Figure 2) . The serum creatinine at last follow-up was 1.49 (range 0.8-2.8) mg/dL (normal values: female 0.5-1.0 mg/dL, male 0.7-1.2 mg/dL). The weight of the removed kidneys ranged from 414 to 8850 g (mean 2002 g). Histological evaluation revealed a total of 13 papillary adenomas. There were no clear cell carcinomas. Mean operative time was 174 min (106-301 min) and patients were discharged on postoperative day 20 (median, range 12-52 days). A total of 19 patients underwent re-operation. The frequency of surgical complications, which might be associated with simultaneous nephrectomy requiring re-operation, was 12% (lymphocele 4%, hernia 4%, post-operative haematoma or bleeding 4%). Of the four patients who underwent re-operation for haematoma or post-operative bleeding, two had venous bleeding (one patient, repetitively) from the site of the removed polycystic kidney. The remaining two patients underwent re-operation for evacuation of retroperitoneal haematoma without signs of ongoing bleeding. In these patients, a correlation with either the renal transplantation itself or the concomitant nephrectomy was not possible. Other surgical complications like ureteral stenosis or urinary leakage as well as vascular complications at the site of kidney engrafting were obviously not associated with concomitant nephrectomy. No deep wound infections were encountered, superficial wound infections occurred in 3% of cases. None of the patients died of the procedure. One patient developed severe pneumonia requiring temporary mechanical ventilation. We observed one myocardial infarction in a patient with advanced coronary heart disease leading to cardiogenic shock. Fortunately, symptoms fully resolved after prompt double aortocoronary bypass surgery. Surgical and non-surgical peri-operative complications are summarized in Table 2 .
The fate of the remaining kidney
The fate of the remaining kidney could be determined for all patients. Twenty-two patients had the contralateral side removed before they were transplanted for various reasons, mostly bleeding and infection. Of the remaining 78 patients, 20 patients (25.6%) have been nephrectomized at the contralateral side after having received their transplant. In two patients, this was done during re-transplantation after failure of the initial graft. One of them was transplanted at the beginning and re-transplanted at the end of this series. This case has been accounted for as two separate cases. One patient had post-transplant nephrectomy for suspected and eventually histologically confirmed urothelial carcinoma. One patient underwent urgent nephrectomy for bleeding. The remaining kidney was removed after a mean of 38 months, ranging from 5 to 153 months. All post-transplant nephrectomies of the contralateral side were also carried out using a retroperitoneal open approach. In 57 patients, the remaining kidney is still in situ and under routine medical surveillance.
Discussion
This is the first report of 100 patients with ADPKD consecutively undergoing renal transplantation with simultaneous unilateral nephrectomy as a standard surgical procedure. Especially for patients with ADPKD, there is an ongoing debate concerning the indication, the timing and the approach of native nephrectomy [20] . Although pre-transplant bilateral nephrectomy should be avoided in the face of preserved endogenous erythropoietin production [21] and better quality of life by sustained urine excretion [22] , retained polycystic kidneys can provoke complications after renal transplantation necessitating nephrectomy later on [23] . Concomitant unilateral nephrectomy has the advantage to reduce the total number of surgical procedures compared to the sandwich technique. Based upon the decreased morbidity of nephrectomy [24] [25] [26] and the potential benefits concerning retained polycystic kidneys prior to transplantation, some reports suggested native nephrectomy to be performed simultaneously to kidney grafting [8, 12-14, 17, 18, 27] . The simultaneous ipsilateral procedure has become increasingly applied at our institution since 1987. Based upon positive clinical results gained with this procedure and the high rate of post-operative contentment experienced by our patients [12] , renal transplantation with simultaneous native unilateral nephrectomy became the standard procedure for all ADPKD patients. In turn, also small kidneys (the smallest weighing only 414 g) were removed and patients were included in this series. The inclusion of all patients with ADPKD in this series, in our view, facilitates the apprehension of possible complications since no surgeon-based bias is introduced. Therefore, also other influencing factors like elective versus non-elective surgery or day versus nighttime surgery are absent.
Surgical considerations
Unilateral nephrectomy can be accomplished via an extension of the Gibson incision. Operation time was only extended by 20-45 min in contrast to bilateral simultaneous nephrectomy, which is performed via a transperitoneal access and lengthens operation time by 190 min [15] . Other centres report operation times of up to 7.5 h with simultaneous bilateral procedure [14, 27] . The advantages of an extraperitoneal access have been highlighted in several other publications [13, 24, 28] . During the last decade, several studies on renal transplantation with concomitant unilateral [8, 12, 13, 17, 18] or bilateral native nephrectomy [14] [15] [16] in patients with ADPKD have been published indicating the general safety and feasibility of this procedure. However, the individual number of cases was rather small ranging from only 13 to 20 patients [8, [13] [14] [15] [16] [17] [18] . In addition, simultaneous nephrectomy was mostly performed together with living-donor renal transplantation instead of deceased donor transplantation. In contrast, the majority of patients included in our study population were deceased donor renal transplants (62%), which are more likely to be transplanted on the weekend or at night. This underlines the feasibility of simultaneous native nephrectomy as a standard procedure in patients with ADPKD also in routine transplant service.
In the present study, all complications that could be directly or indirectly related to the additional procedure were regarded as complications of concomitant nephrectomy, although it is likely that some complications like post-operative haematoma and hernia as well as lymphoceles could have also occurred after renal transplantation alone. For patients not undergoing the concomitant approach, it is important to consider that in the case of nephrectomy after renal transplantation, the complication rate of each procedure has to be totalized when compared to our simultaneous approach.
All adverse events were successfully managed and the patient's recovery was uneventful after surgical re-intervention except for one repetitive bleeding from the site of nephrectomy requiring a total of three surgical reinterventions.
Graft survival
Graft survival was 96 and 80% at 1 and 5 years, respectively, which matches results of other reports with simultaneous nephrectomy [21, 29] . It also compares favourably to the analysis of large databases like the Collaborative Transplant Study for renal transplantation in ADPKD patients without concomitant native nephrectomy (www.cts.med.uni-heidelberg.de). This pool of data indicates that the simultaneous procedure does not appear to adversely impact short-and long-term graft and patient survival.
Moreover, the course and severity of ADPKD-related complications show a wide range of variance among patients and complications may fail to arise until renal transplantation [1] . Recent data indicate that >40% of patients with a native kidney left in situ who were followed after transplantation eventually required nephrectomy due to complications in the long term [23] . In this study, complication rates and graft losses were highest among patients without pre-transplantation nephrectomy [23] . Therefore, ongoing haematuria and recurrent infections after kidney engrafting might jeopardize the function of the transplanted graft as well as the immunocompromised patient itself. Several other studies indicate a significantly better graft function and post-operative survival for patients undergoing pre-transplant unilateral or bilateral nephrectomy compared to patients without this additional procedure [7, 21, 30, 31] . The most common cause of an impaired patient and graft survival were found to be septic complications directly related to the polycystic kidneys [7, 21, 30, 31] .
The fate of the remaining kidney
We believe that safe nephrectomy on the contralateral side can be carried out at ∼3 months post-transplant, if renal function is stable. In reality, the remaining kidney was removed after a mean of 38 months, ranging from 5 to 153 months. Since there was no 'per protocol' intention to remove the contralateral kidney, it is of note that of 78 patients with the contralateral kidney in situ at the time of transplantation, only 26% underwent subsequent nephrectomy for various reasons including suspected malignancy and bleeding.
Conclusions
Our data indicate that simultaneous ipsilateral nephrectomy at the time of kidney transplantation in patients with ADPKD can be safely performed without compromising patient and graft survival rates. Due to high patient contentment and prevention of possible cyst-related complications arising after transplantation, we believe that concomitant nephrectomy can be increasingly offered to patients with ADPKD and end-stage renal failure as it did not significantly increase morbidity and mortality rates in this series. Whether there is any inherent benefit in this technique, which warrants its use for all ADPKD patients at the time of transplantation in other centres, can only be shown in a randomized multicentre trial. However, these results might be helpful for the decision making of surgeons treating symptomatic patients with ADPKD and end-stage renal disease awaiting kidney transplantation.
